Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldblatt

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
Plos Genetics|August 8, 2014
Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genesClaire Chewapreecha, Pekka Marttinen, Nicholas J Croucher, et al.
The Journal of Infectious Diseases|July 25, 2024
Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent Pneumococcal Conjugate Vaccine IntroductionAkuzike Kalizang'oma, Todd D Swarthout, Thandie S Mwalukomo, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trialEd Clarke, Adedapo O Bashorun, Michael Okoye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2019
Thirteen-Valent Pneumococcal Conjugate Vaccine in Children With Acute Lymphoblastic Leukemia: Protective Immunity Can Be Achieved on Completion of TreatmentJessica Bate, Ray Borrow, Julia Chisholm, et al.
Vaccine|April 30, 2019
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultationsJohan Vekemans, Jonathan Crofts, Carol J Baker, et al.
Vaccine|April 12, 2023
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (Synflorix<sup>TM</sup> and Prevenar13<sup>TM)</sup>) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian childrenAnand Kawade, Girish Dayma, Aditi Apte, et al.
Vaccine|October 15, 2013
Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster doseEls van Westen, Gerwin D Rodenburg, Elske J M van Gils, et al.
The Lancet. Infectious Diseases|January 11, 2021
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trialKimberly Davis, Marta Valente Pinto, Nick J Andrews, et al.
Vaccines|April 3, 2021
Protective Effect of Nasal Colonisation with <i>∆cps/piaA</i> and <i>∆cps/proABC</i><i>Streptococcus pneumoniae</i> Strains against Recolonisation and Invasive InfectionElisa Ramos-Sevillano, Giuseppe Ercoli, José Afonso Guerra-Assunção, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2021
Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2Louis Grandjean, Anja Saso, Arturo Torres Ortiz, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Plos Genetics|August 8, 2014
Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genesClaire Chewapreecha, Pekka Marttinen, Nicholas J Croucher, et al.
The Journal of Infectious Diseases|July 25, 2024
Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent Pneumococcal Conjugate Vaccine IntroductionAkuzike Kalizang'oma, Todd D Swarthout, Thandie S Mwalukomo, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trialEd Clarke, Adedapo O Bashorun, Michael Okoye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2019
Thirteen-Valent Pneumococcal Conjugate Vaccine in Children With Acute Lymphoblastic Leukemia: Protective Immunity Can Be Achieved on Completion of TreatmentJessica Bate, Ray Borrow, Julia Chisholm, et al.
Vaccine|April 30, 2019
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultationsJohan Vekemans, Jonathan Crofts, Carol J Baker, et al.
Vaccine|April 12, 2023
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (Synflorix<sup>TM</sup> and Prevenar13<sup>TM)</sup>) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian childrenAnand Kawade, Girish Dayma, Aditi Apte, et al.
Vaccine|October 15, 2013
Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster doseEls van Westen, Gerwin D Rodenburg, Elske J M van Gils, et al.
The Lancet. Infectious Diseases|January 11, 2021
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trialKimberly Davis, Marta Valente Pinto, Nick J Andrews, et al.
Vaccines|April 3, 2021
Protective Effect of Nasal Colonisation with <i>∆cps/piaA</i> and <i>∆cps/proABC</i><i>Streptococcus pneumoniae</i> Strains against Recolonisation and Invasive InfectionElisa Ramos-Sevillano, Giuseppe Ercoli, José Afonso Guerra-Assunção, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2021
Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2Louis Grandjean, Anja Saso, Arturo Torres Ortiz, et al.
Pageof 25